熱門資訊> 正文
Autolus Therapeutics 2026年第二季度盈利预览
2026-08-10 23:00
- Autolus Therapeutics (AUTL) is scheduled to announce Q2 earnings results on Tuesday, August 11th, before market open.
- The consensus EPS Estimate is -$0.19 (-5.6% Y/Y) and the consensus Revenue Estimate is $40.15M (+92.1% Y/Y).
- Over the last 1 year, AUTL has beaten EPS estimates 50% of the time and has beaten revenue estimates 25% of the time.
- Over the last 3 months, EPS estimates have seen 6 upward revisions and 0 downward. Revenue estimates have seen 5 upward revisions and 0 downward.
More on Autolus Therapeutics
- Autolus Therapeutics: Navigating A Bumpy 2026
- Autolus Therapeutics plc (AUTL) Q1 2026 Earnings Call Transcript
- Autolus Therapeutics plc 2026 Q1 - Results - Earnings Call Presentation
- Autolus reiterates $120M-$135M 2026 AUCATZYL revenue guidance as it targets 65%-70% peak ALL gross margin
- Autolus Therapeutics Q1 2026 Earnings Preview
推薦文章
美股前瞻 | 史詩級「軋空」來襲！比特幣升破7.2萬美元；業績股齊遇冷！沃爾瑪盤前大跌逾6%，阿里、網易均跌近4%
一圖看懂 | 泡泡瑪特上半年營收171億、淨利50億均大遜預期！星星人IP逆勢暴漲580%；王寧稱計劃半年內大額回購20-50億
Moderna暴漲177%！mRNA癌症疫苗迎來「ChatGPT時刻」？16只港美標的誰會接過下一棒？
「影子股」已暴漲90%！如何在Anthropic史上最大IPO前搶跑入局？最全攻略來了
港股異動 | 全球首個mRNA癌症疫苗三期成功落地！港股醫藥股齊衝高，康希諾生物飆升49%，雲頂新耀勁升42%
資金流向顯示億萬富豪Ken Fisher旗下機構以40億美元逆勢抄底長期美債
SK海力士出手救市！擬回購並註銷約283億美元的股票
賽力斯港股上市后首虧!半年虧掉17億,狂燒70億搞研發
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
